灵康药业
(603669)
| 流通市值：37.11亿 | | | 总市值：37.11亿 |
| 流通股本：7.12亿 | | | 总股本：7.12亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 150,536,474.98 | 160,778,716.72 | 142,023,593.85 | 155,511,476.13 |
| 交易性金融资产 | 6,743,491.63 | 4,306,302.69 | 14,814,420.46 | 13,318,533.53 |
| 应收票据及应收账款 | 327,458,902.35 | 292,122,642.26 | 283,010,780.01 | 256,106,844.04 |
| 应收账款 | 327,458,902.35 | 292,122,642.26 | 283,010,780.01 | 256,106,844.04 |
| 应收款项融资 | 3,968,180.15 | 2,606,698.48 | - | 109,880 |
| 预付款项 | 10,235,732.73 | 7,239,652.19 | 10,690,510.99 | 8,275,275.77 |
| 其他应收款合计 | 8,941,490.27 | 8,342,760.35 | 2,447,398.77 | 2,397,402.44 |
| 存货 | 71,144,483.42 | 75,815,052.25 | 77,270,067.06 | 84,030,714.01 |
| 其他流动资产 | 9,271,294.7 | 5,813,968.69 | 11,719,014.78 | 5,628,830.59 |
| 流动资产合计 | 588,300,050.23 | 557,025,793.63 | 541,975,785.92 | 525,378,956.51 |
| 非流动资产: | | | | |
| 长期股权投资 | 14,057,858.68 | 13,911,964.89 | 14,285,445.87 | 14,417,743.43 |
| 其他权益工具投资 | 50,046,715.68 | 50,046,715.68 | 50,046,715.68 | 50,046,715.68 |
| 投资性房地产 | 7,867,704.13 | 7,997,032.87 | 8,126,361.58 | 6,606,258.37 |
| 固定资产 | 194,271,107.38 | 198,982,190.11 | 207,225,772.45 | 209,061,714.55 |
| 在建工程 | 190,834,392.07 | 190,834,392.07 | 190,834,392.07 | 190,834,392.07 |
| 使用权资产 | 3,875,560.91 | 4,340,628.23 | 4,805,695.55 | 5,270,762.87 |
| 无形资产 | 88,625,705.68 | 90,391,759.52 | 93,180,829.38 | 93,611,430.59 |
| 长期待摊费用 | 9,368,353.45 | 10,053,460.48 | 10,738,567.51 | 11,423,674.54 |
| 其他非流动资产 | 467,819 | 452,819 | 452,819 | 127,819 |
| 非流动资产合计 | 559,415,216.98 | 567,010,962.85 | 579,696,599.09 | 581,400,511.1 |
| 资产总计 | 1,147,715,267.21 | 1,124,036,756.48 | 1,121,672,385.01 | 1,106,779,467.61 |
| 流动负债: | | | | |
| 短期借款 | 15,006,944.45 | 15,006,944.45 | 15,006,944.45 | 15,011,222.23 |
| 应付票据及应付账款 | 141,645,946.41 | 114,977,167.23 | 140,157,019.33 | 129,119,571.95 |
| 其中：应付票据 | 24,101,438 | - | 30,000,000 | 30,000,000 |
| 应付账款 | 117,544,508.41 | 114,977,167.23 | 110,157,019.33 | 99,119,571.95 |
| 预收款项 | 436,104.49 | 566,878.66 | 553,672.75 | 338,285.76 |
| 合同负债 | 9,670,670.31 | 9,307,924.63 | 11,447,889.34 | 11,429,271.62 |
| 应付职工薪酬 | 2,110,734.9 | 2,285,824.55 | 2,079,028.4 | 5,990,179.14 |
| 应交税费 | 3,757,001.7 | 20,017,558.95 | 8,164,419.14 | 6,670,960.09 |
| 其他应付款合计 | 3,863,915.66 | 6,679,341.29 | 11,510,502.21 | 32,808,211.01 |
| 一年内到期的非流动负债 | 292,493,552.11 | 287,181,005.16 | 281,864,257.65 | 274,540,793.88 |
| 其他流动负债 | 2,000,956.81 | 2,041,820.43 | 1,791,175.08 | 2,673,244.94 |
| 流动负债合计 | 470,985,826.84 | 458,064,465.35 | 472,574,908.35 | 478,581,740.62 |
| 非流动负债: | | | | |
| 长期借款 | 17,000,000 | 17,000,000 | 18,000,000 | - |
| 租赁负债 | 2,130,682.94 | 2,130,682.94 | 2,130,682.94 | 2,130,682.94 |
| 递延收益 | 4,298,683.44 | 4,354,839.35 | 4,410,995.26 | 4,467,151.17 |
| 递延所得税负债 | 968,890.23 | 1,085,157.08 | 1,317,690.72 | 1,317,690.72 |
| 非流动负债合计 | 24,398,256.61 | 24,570,679.37 | 25,859,368.92 | 7,915,524.83 |
| 负债合计 | 495,384,083.45 | 482,635,144.72 | 498,434,277.27 | 486,497,265.45 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 712,360,379 | 712,331,165 | 721,246,136 | 721,246,136 |
| 其他权益工具 | 60,430,766.24 | 60,475,950.71 | 60,477,385.14 | 60,477,385.14 |
| 资本公积 | 253,558,643.23 | 253,327,009.63 | 304,404,271.94 | 304,404,271.94 |
| 减:库存股 | 50,019,438.2 | 50,019,438.2 | 110,019,822.2 | 110,019,822.2 |
| 其他综合收益 | -263,450.11 | -263,450.11 | -263,450.11 | -263,450.11 |
| 盈余公积 | 144,362,187.9 | 144,362,187.9 | 144,362,187.9 | 144,362,187.9 |
| 未分配利润 | -468,097,904.3 | -478,811,813.17 | -496,968,600.93 | -499,924,506.51 |
| 归属于母公司股东权益合计 | 652,331,183.76 | 641,401,611.76 | 623,238,107.74 | 620,282,202.16 |
| 股东权益合计 | 652,331,183.76 | 641,401,611.76 | 623,238,107.74 | 620,282,202.16 |
| 负债和股东权益合计 | 1,147,715,267.21 | 1,124,036,756.48 | 1,121,672,385.01 | 1,106,779,467.61 |
| 公告日期 | 2026-10-24 | 2026-08-15 | 2026-04-29 | 2026-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |